175 related articles for article (PubMed ID: 34588605)
1. A human antibody against human endothelin receptor type A that exhibits antitumor potency.
Ju MS; Ahn HM; Han SG; Ko S; Na JH; Jo M; Lim CS; Ko BJ; Yu YG; Lee WK; Kim YJ; Jung ST
Exp Mol Med; 2021 Sep; 53(9):1437-1448. PubMed ID: 34588605
[TBL] [Abstract][Full Text] [Related]
2. Engineered Human Antibody with Improved Endothelin Receptor Type A Binding Affinity, Developability, and Serum Persistence Exhibits Excellent Antitumor Potency.
Ko S; Ju MS; Ahn HM; Na JH; Ko WH; Jo M; Kyung M; Lim CS; Ko BJ; Lee WK; Kim YJ; Jung ST
Mol Pharm; 2023 Feb; 20(2):1247-1255. PubMed ID: 36563318
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways.
Maguire JJ; Kuc RE; Pell VR; Green A; Brown M; Kumar S; Wehrman T; Quinn E; Davenport AP
Life Sci; 2012 Oct; 91(13-14):544-9. PubMed ID: 22480514
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of a target-selectively activated antibody against epidermal growth factor receptor with enhanced anti-tumor potency.
Yang Y; Guo Q; Xia M; Li Y; Peng X; Liu T; Tong X; Xu J; Guo H; Qian W; Hou S; Dai J; Wang H; Liu R; Guo Y
MAbs; 2015; 7(2):440-50. PubMed ID: 25679409
[TBL] [Abstract][Full Text] [Related]
5. Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.
Kaneko MK; Kunita A; Yamada S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Ogasawara S; Ohishi T; Abe S; Itai S; Harada H; Kawada M; Nishioka Y; Fukayama M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):157-162. PubMed ID: 28665782
[TBL] [Abstract][Full Text] [Related]
6. Antibodies targeting human endothelin-1 receptors reveal different conformational states in cancer cells.
Herbet A; Costa N; Leventoux N; Mabondzo A; Couraud JY; Borrull A; Hugnot JP; Boquet D
Physiol Res; 2018 Jun; 67(Suppl 1):S257-S264. PubMed ID: 29947545
[TBL] [Abstract][Full Text] [Related]
7. Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with
Ohishi T; Kato Y; Kaneko MK; Ohba SI; Inoue H; Harakawa A; Kawada M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839411
[TBL] [Abstract][Full Text] [Related]
8. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y
Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-A receptor in gastric cancer and enhanced antitumor activity of trastuzumab in combination with the endothelin-A receptor antagonist ZD4054.
Shen W; Xi H; Li C; Bian S; Cheng H; Cui J; Wang N; Wei B; Huang X; Chen L
Ann N Y Acad Sci; 2019 Jul; 1448(1):30-41. PubMed ID: 30937921
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
Miao G; Sun X
Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
[TBL] [Abstract][Full Text] [Related]
11. Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
Yuyama H; Noguchi Y; Fujimori A; Ukai M; Fujiyasu N; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K
Eur J Pharmacol; 2004 Sep; 498(1-3):171-7. PubMed ID: 15363992
[TBL] [Abstract][Full Text] [Related]
12. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
13. Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists.
Ksander GM; Shetty SS; DelGrande D; Balwierczak JL; Bruseo CW; Savage P; deJesus R; Yuan A; Webb RL; Jeng AY
Can J Physiol Pharmacol; 2002 May; 80(5):464-9. PubMed ID: 12056554
[TBL] [Abstract][Full Text] [Related]
14. ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
Kaneko MK; Nakamura T; Kunita A; Fukayama M; Abe S; Nishioka Y; Yamada S; Yanaka M; Saidoh N; Yoshida K; Fujii Y; Ogasawara S; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):104-112. PubMed ID: 28504613
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
Sudoh K; Yuyama H; Noguchi Y; Fujimori A; Ukai M; Ohtake A; Sato S; Sasamata M; Miyata K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S390-3. PubMed ID: 15838329
[TBL] [Abstract][Full Text] [Related]
16. Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor.
Allard B; Priam F; Deshayes F; Ducancel F; Boquet D; Wijkhuisen A; Couraud JY
DNA Cell Biol; 2011 Sep; 30(9):727-37. PubMed ID: 21688998
[TBL] [Abstract][Full Text] [Related]
17. Endothelin receptor heteromerization inhibits β-arrestin function in HEK293 cells.
Zrein A; Bagher AM; Young AP; Denovan-Wright EM; Kelly MEM
Can J Physiol Pharmacol; 2020 Aug; 98(8):531-540. PubMed ID: 32744876
[TBL] [Abstract][Full Text] [Related]
18. Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats.
Mirabito Colafella KM; Neves KB; Montezano AC; Garrelds IM; van Veghel R; de Vries R; Uijl E; Baelde HJ; van den Meiracker AH; Touyz RM; Danser AHJ; Versmissen J
Cardiovasc Res; 2020 Aug; 116(10):1779-1790. PubMed ID: 31593221
[TBL] [Abstract][Full Text] [Related]
19. Potential role for ET-2 acting through ETA receptors in experimental colitis in mice.
Claudino RF; Leite DF; Bento AF; Chichorro JG; Calixto JB; Rae GA
Inflamm Res; 2017 Feb; 66(2):141-155. PubMed ID: 27778057
[TBL] [Abstract][Full Text] [Related]
20. Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells.
Fischgräbe J; Götte M; Michels K; Kiesel L; Wülfing P
Int J Cancer; 2010 Aug; 127(3):696-706. PubMed ID: 19960438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]